A user guide to the American Society of Hematology clinical practice guidelines.


Journal

Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425

Informations de publication

Date de publication:
12 05 2020
Historique:
received: 28 02 2020
accepted: 25 03 2020
entrez: 13 5 2020
pubmed: 13 5 2020
medline: 15 5 2021
Statut: ppublish

Résumé

Since November 2018, Blood Advances has published American Society of Hematology (ASH) clinical practice guidelines on venous thromboembolism, immune thrombocytopenia, and sickle cell disease. More ASH guidelines on these and other topics are forthcoming. These guidelines have been developed using consistent processes, methods, terminology, and presentation formats. In this article, we describe how patients, clinicians, policymakers, researchers, and others may use ASH guidelines and the many related derivates by describing how to interpret information and how to apply it to clinical decision-making. Also, by exploring how these documents are developed, we aim to clarify their limitations and possible inappropriate usage.

Identifiants

pubmed: 32396622
pii: S2473-9529(20)31342-2
doi: 10.1182/bloodadvances.2020001755
pmc: PMC7218428
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2095-2110

Subventions

Organisme : NHLBI NIH HHS
ID : K01 HL135466
Pays : United States

Informations de copyright

© 2020 by The American Society of Hematology.

Références

Blood Adv. 2018 Nov 27;2(22):3198-3225
pubmed: 30482763
Ann Intern Med. 2019 Aug 20;171(4):273-280
pubmed: 31330534
J Clin Epidemiol. 2019 Jul;111:94-104
pubmed: 29452223
Blood Adv. 2020 Apr 28;4(8):1554-1588
pubmed: 32298430
BMJ. 2008 May 17;336(7653):1106-10
pubmed: 18483053
Res Synth Methods. 2018 Jul 14;:
pubmed: 30006970
BMC Med. 2016 Feb 10;14:22
pubmed: 26860831
BMJ. 2004 Jun 19;328(7454):1490
pubmed: 15205295
J Clin Epidemiol. 2016 Jul;75:6-15
pubmed: 27063205
J Clin Epidemiol. 2013 Jul;66(7):719-25
pubmed: 23312392
J Clin Epidemiol. 2017 Jul;87:4-13
pubmed: 28529184
BMJ. 2016 Jun 28;353:i2016
pubmed: 27353417
J Clin Epidemiol. 2017 Jan;81:101-110
pubmed: 27713072
Blood Adv. 2018 Nov 27;2(22):3226-3256
pubmed: 30482764
J Clin Epidemiol. 2011 Apr;64(4):395-400
pubmed: 21194891
CMAJ. 2014 Feb 18;186(3):E123-42
pubmed: 24344144
J Clin Epidemiol. 2019 Jul;111:83-93
pubmed: 29800687
J Clin Epidemiol. 2020 Jun;122:142-152
pubmed: 32058069
Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):387-92
pubmed: 25696883
Blood Adv. 2019 Dec 10;3(23):3898-3944
pubmed: 31794602
Blood Adv. 2019 Dec 10;3(23):3829-3866
pubmed: 31794604
CMAJ. 2003 Sep 30;169(7):677-80
pubmed: 14517128
Blood Adv. 2019 Dec 10;3(23):3867-3897
pubmed: 31794601
Ann Intern Med. 2020 Jan 7;172(1):46-56
pubmed: 31766052
Blood Adv. 2018 Nov 27;2(22):3257-3291
pubmed: 30482765
Blood Adv. 2018 Nov 27;2(22):3360-3392
pubmed: 30482768
Ann Intern Med. 2015 Oct 6;163(7):548-53
pubmed: 26436619
J Clin Epidemiol. 2019 Jul;111:69-82
pubmed: 30738926
Lancet. 2016 Nov 26;388(10060):2629-2641
pubmed: 27720497
PLoS Med. 2007 May;4(5):e119
pubmed: 17535099
Allergy. 2009 May;64(5):669-77
pubmed: 19210357
Proc Am Thorac Soc. 2012 Dec;9(5):215-8
pubmed: 23256161
Blood Adv. 2020 Mar 10;4(5):953-968
pubmed: 32150612
J Clin Epidemiol. 2020 Jun;122:129-141
pubmed: 32060007
Blood Adv. 2020 Jan 28;4(2):327-355
pubmed: 31985807
Health Res Policy Syst. 2006 Nov 20;4:12
pubmed: 17116254
Implement Sci. 2013 Jan 09;8:6
pubmed: 23302501
Blood Adv. 2018 Nov 27;2(22):3292-3316
pubmed: 30482766
PLoS One. 2020 Feb 12;15(2):e0229004
pubmed: 32050261
Ann Intern Med. 2012 Apr 3;156(7):525-31
pubmed: 22473437
Blood Adv. 2020 May 26;4(10):2351-2365
pubmed: 32453843
J Clin Epidemiol. 2016 Aug;76:89-98
pubmed: 26931285
Blood Adv. 2018 Nov 27;2(22):3317-3359
pubmed: 30482767
BMJ. 2016 Jun 30;353:i2089
pubmed: 27365494
J Clin Epidemiol. 2013 Jul;66(7):726-35
pubmed: 23570745
Am J Respir Crit Care Med. 2008 Nov 15;178(10):1009-16
pubmed: 18776152
Implement Sci. 2012 Jul 04;7:62
pubmed: 22762242
Health Qual Life Outcomes. 2020 Jun 5;18(1):167
pubmed: 32503619
Blood Adv. 2020 Oct 13;4(19):4693-4738
pubmed: 33007077
J Clin Epidemiol. 2016 Dec;80:3-7
pubmed: 27452192
BMJ. 2019 Jul 19;366:l4606
pubmed: 31324659
Implement Sci. 2012 Jul 04;7:60
pubmed: 22762776
J Clin Epidemiol. 2011 Apr;64(4):383-94
pubmed: 21195583

Auteurs

Ariel Izcovich (A)

Department of Internal Medicine, German Hospital, Buenos Aires, Argentina.

Adam Cuker (A)

Department of Medicine and.
Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

Robert Kunkle (R)

American Society of Hematology, Washington, DC.

Ignacio Neumann (I)

Department of Internal Medicine and.
Centro Evidencia UC, Pontificia Universidad Católica de Chile, Santiago, Chile.

Julie Panepinto (J)

Children's of Wisconsin, Medical College of Wisconsin, Milwaukee, WI.

Menaka Pai (M)

Department of Medicine, McMaster University, Hamilton, ON, Canada.

Matthew Seftel (M)

Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

Matthew C Cheung (MC)

Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.

Richard Lottenberg (R)

Division of Hematology/Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL.

Michael Byrne (M)

Division of Hematology/Oncology, Department of Medicine, Vanderbilt University, Nashville, TN.

Robert Plovnick (R)

American Society of Hematology, Washington, DC.

Deirdra Terrell (D)

Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK.

Jennifer L Holter-Chakrabarty (JL)

Stephenson Cancer Center, Division of Hematology/Oncology/Transplantation and Cellular Therapy, Department of Medicine, University of Oklahoma, Oklahoma City, OK.

Benjamin Djulbegovic (B)

Department of Supportive Care Medicine and.
Department of Hematology, City of Hope, Duarte, CA.

Lisa K Hicks (LK)

Department of Medicine, St. Michael's Hospital, Toronto, ON, Canada.
Faculty of Medicine, University of Toronto, Toronto, ON, Canada; and.

Wojtek Wiercioch (W)

Michael G. DeGroote Cochrane Canada Centre.
McMaster GRADE Centre, and.
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.

Robby Nieuwlaat (R)

Michael G. DeGroote Cochrane Canada Centre.
McMaster GRADE Centre, and.
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.

Holger J Schünemann (HJ)

Department of Medicine, McMaster University, Hamilton, ON, Canada.
Michael G. DeGroote Cochrane Canada Centre.
McMaster GRADE Centre, and.
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH